SCPC’s recommendations focused on the value of LTC pharmacy services to improve outcomes and reduce costs for dual eligibles who need long-term services.
The organization publicly commends the administration’s efforts to standardize plan choice by requiring generic drugs be placed on generic tiers and brand-name drugs on brand-name tiers.